The regulation of devices in the US is going through a transitional phase which should result in an improved FDA that can adapt to changing technology while setting clear standards, FDA Commissioner Joshua Sharfstein told medtech executives. Mr Sharfstein, in his seventh month in the hot seat, ...
Please Login to read the full article.
